Johns Hopkins scientists prep PhI combo study for ovarian cancer; Maryland investigator finds flu 'decoy';

> Johns Hopkins scientists say that Rigel's experimental drug fostamatinib could help overcome ovarian cancer cells' resistance to paclitaxel. And now they are planning a Phase I study to test the theory in humans. Release

> A University of Maryland School of Medicine researcher says he has found a "decoy" molecule that can help prevent a runaway immune response to the flu virus. Release

> Scientists from the Florida campus of The Scripps Research Institute say they have found that microRNA plays "surprisingly different roles in the formation of memory in animal models. In some cases, these RNAs increase memory, while others decrease it." Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.